Medulloblastoma accounts for approximately 20% of primary intracerebral turnouts in children and the 5-year survival is still in the region of 40% [1,5]. Several studies have shown that recurrent medulloblastoma sometimes responds to chemotherapy; the drugs most widely used are nitrosoureas, procarb
Genetics of recurrent medulloblastoma
β Scribed by Zollo, Massimo
- Book ID
- 122334428
- Publisher
- The Lancet
- Year
- 2013
- Tongue
- English
- Weight
- 276 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1470-2045
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Previously irradiated recurrent medulloblastoma (MB) is a highly lethal disease. Reirradiation is often not considered secondary to its potential toxicity and uncertain efficacy. Analysis of retreatment could help identify the feasibility and role of reirradiation for re
## Abstract Magnetic resonance imaging (MRI) is becoming the method of choice for evaluation of central nervous system tumors. However, the sensitivity of this modality raises concern that new lesions in patients previously diagnosed with a brain tumor may not necessarily represent recurrent diseas